South Korea · Delayed Price · Currency is KRW CORESTEMCHEMON Statistics
Total Valuation
CORESTEMCHEMON has a market cap or net worth of KRW 112.23 billion. The enterprise value is 142.99 billion.
| Market Cap | 112.23B |
| Enterprise Value | 142.99B |
Important Dates
The next estimated earnings date is Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CORESTEMCHEMON has 44.36 million shares outstanding. The number of shares has increased by 17.21% in one year.
| Current Share Class | 44.36M |
| Shares Outstanding | 44.36M |
| Shares Change (YoY) | +17.21% |
| Shares Change (QoQ) | +4.77% |
| Owned by Insiders (%) | 11.61% |
| Owned by Institutions (%) | 0.04% |
| Float | 39.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.57 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.33 |
| EV / Sales | 7.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.98 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.71.
| Current Ratio | 0.46 |
| Quick Ratio | 0.31 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.44 |
| Interest Coverage | -12.62 |
Financial Efficiency
Return on equity (ROE) is -51.72% and return on invested capital (ROIC) is -29.07%.
| Return on Equity (ROE) | -51.72% |
| Return on Assets (ROA) | -11.57% |
| Return on Invested Capital (ROIC) | -29.07% |
| Return on Capital Employed (ROCE) | -28.30% |
| Weighted Average Cost of Capital (WACC) | 8.86% |
| Revenue Per Employee | 559.97M |
| Profits Per Employee | -745.37M |
| Employee Count | 36 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 70.85 |
Taxes
In the past 12 months, CORESTEMCHEMON has paid 40.05 million in taxes.
| Income Tax | 40.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.06% in the last 52 weeks. The beta is 1.18, so CORESTEMCHEMON's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -20.06% |
| 50-Day Moving Average | 2,834.40 |
| 200-Day Moving Average | 2,339.44 |
| Relative Strength Index (RSI) | 47.95 |
| Average Volume (20 Days) | 463,672 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CORESTEMCHEMON had revenue of KRW 20.16 billion and -26.83 billion in losses. Loss per share was -903.00.
| Revenue | 20.16B |
| Gross Profit | -4.15B |
| Operating Income | -21.27B |
| Pretax Income | -26.79B |
| Net Income | -26.83B |
| EBITDA | -17.11B |
| EBIT | -21.27B |
| Loss Per Share | -903.00 |
Balance Sheet
The company has 8.14 billion in cash and 38.90 billion in debt, with a net cash position of -30.76 billion or -693.37 per share.
| Cash & Cash Equivalents | 8.14B |
| Total Debt | 38.90B |
| Net Cash | -30.76B |
| Net Cash Per Share | -693.37 |
| Equity (Book Value) | 55.17B |
| Book Value Per Share | 1,413.45 |
| Working Capital | -20.26B |
Cash Flow
In the last 12 months, operating cash flow was -13.87 billion and capital expenditures -2.06 billion, giving a free cash flow of -15.92 billion.
| Operating Cash Flow | -13.87B |
| Capital Expenditures | -2.06B |
| Depreciation & Amortization | 4.31B |
| Net Borrowing | 2.11B |
| Free Cash Flow | -15.92B |
| FCF Per Share | -358.93 |
Margins
Gross margin is -20.57%, with operating and profit margins of -105.50% and -133.11%.
| Gross Margin | -20.57% |
| Operating Margin | -105.50% |
| Pretax Margin | -132.91% |
| Profit Margin | -133.11% |
| EBITDA Margin | -84.87% |
| EBIT Margin | -105.50% |
| FCF Margin | n/a |
Dividends & Yields
CORESTEMCHEMON does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.21% |
| Shareholder Yield | -17.21% |
| Earnings Yield | -23.91% |
| FCF Yield | -14.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CORESTEMCHEMON has an Altman Z-Score of -1.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.42 |
| Piotroski F-Score | 3 |